Approval · Notice of Compliance 643 · 2002
REFLUDAN: Notice of Compliance 643
Issued June 28, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 643
- Date
- June 28, 2002
- Company
- Berlex Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
- Therapeutic class
- Antithrombotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REFLUDAN | Not yet assigned | — |
Medicinal ingredients
- LEPIRUDIN 50 MG per VIAL